Delivery Order SPE2DP23D0001-SPE2D626F2044
- Not listed
- The Defense Logistics Agency's Medical Supply Chain division awarded a $2,090.49 delivery order to Canadian Commercial Corporation (CCC) on October 16, 2025, for the procurement of Reactive Skin Decontamination Lotion (RSDL) with an ultimate completion date of January 2, 2026. This delivery order carries no set-aside designation and will be performed at CCC's headquarters in Ottawa, Ontario, Canada. CCC, a Crown corporation owned by the Government of Canada, serves as a prime contractor to...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain division awarded a delivery order valued at $2,090.49 to the Canadian Commercial Corporation (CCC) on October 16, 2025, for the procurement of Reactive Skin Decontamination Lotion (RSDL). This is a firm fixed-price delivery order with no set-aside designation, reflecting CCC's status as a government-to-government contracting entity rather than a small business concern. The work is scheduled for completion by January 2, 2026, with...
- This is a $8,361.96 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to the Canadian Commercial Corporation (CCC), a Crown corporation of the Canadian government that serves as a prime contractor to U.S. federal agencies. The contract is for the delivery of Reactive Skin Decontamination Lotion (RSDL), a medical supply used for defense purposes. CCC has been awarded multiple indefinite delivery contracts by various U.S. military commands, demonstrating its ability...
- This is a federal contract awarded by the Defense Logistics Agency (DLA) to the Canadian Commercial Corporation (CCC), a Crown corporation owned by the Government of Canada that serves as a prime contractor to U.S. federal agencies. The contract, valued at $8,361.96, is a delivery order for the provision of Reactive Skin Decontamination Lotion (RSDL), a medical supply used in defense applications. The contract has a firm fixed-price pricing type and an ultimate completion date of May 8, 2025....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to the Canadian Commercial Corporation (CCC), a Crown corporation owned by the Government of Canada that acts as a prime contractor to U.S. federal agencies. The contract, valued at $4,180.98, is for the delivery of Reactive Skin Decontamination Lotion (RSDL), a medical supply used for defense purposes. The contract has a firm fixed price pricing type and an ultimate completion date of April 18, 2025. CCC has been...
- This federal contract award to Canadian Commercial Corporation (CCC), a Canadian government-owned prime contractor, provides the U.S. Defense Logistics Agency (DLA) with Reactive Skin Decontamination Lotion (RSDL) medical supplies. The $209,527.32 firm fixed-price delivery order contract has an ultimate completion date of April 18, 2024. CCC is delivering these mission-critical medical products without any set-aside designation, leveraging its government-to-government contracting expertise to...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to Canadian Commercial Corporation (CCC) on October 2, 2025, for the supply of Inactive Skin Decontamination Lotion 21. This contract, valued at $1,648.86, is a firm fixed-price delivery order with an ultimate completion date of December 18, 2025. The contract carries no set-aside designation, reflecting CCC's role as a Crown corporation facilitating government-to-government contracting between U.S. federal agencies and...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to the Canadian Commercial Corporation (CCC), a Crown corporation owned by the Government of Canada that facilitates government-to-government contracting for Canadian exporters. The $2,090.49 firm fixed-price contract is for the delivery of Reactive Skin Decontamination Lotion (RSDL), a medical supply used by the U.S. military. The contract has an ultimate completion date of April 30, 2025 and does not utilize any set-aside...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to the Canadian Commercial Corporation (CCC), a Crown corporation owned by the Government of Canada. The $4,180.98 firm fixed-price contract is for the delivery of Reactive Skin Decontamination Lotion (RSDL), a medical supply item, with a completion date of April 29, 2025. CCC serves as a prime contractor to U.S. federal agencies, facilitating government-to-government contracting for Canadian exporters. This contract is not...
- This is a delivery order contract awarded by the U.S. Defense Logistics Agency (DLA) to the Canadian Commercial Corporation (CCC) for $2,090.49. The contract is for firm fixed-price delivery of Reactive Skin Decontamination Lotion (RSDL), a medical supply used to treat chemical weapon exposure. The contract has an ultimate completion date of September 26, 2025 and does not utilize a set-aside designation. CCC is a Crown corporation owned by the Government of Canada that serves as a prime...
- SPE2DP23D0001Indefinite Delivery Contract
- SPE2DP23D0001-SPE2D626F2044Delivery Order
The Defense Logistics Agency's Medical Supply Chain division awarded a $2,090.49 delivery order to Canadian Commercial Corporation (CCC) on October 16, 2025, for Reactive Skin Decontamination Lotion (RSDL). CCC, a Canadian Crown corporation and registered foreign government entity, serves as a prime contractor facilitating government-to-government procurement relationships between U.S. defense agencies and Canadian manufacturers. This delivery order carries no set-aside designation, consistent with CCC's role as an intermediary entity rather than a small business concern. The work is scheduled for completion by January 2, 2026, and will be performed at CCC's headquarters in Ottawa, Ontario, Canada. This delivery order represents a continuation of CCC's established role supplying medical supplies and specialized medical equipment to the Defense Logistics Agency's Medical Supply Chain operations. RSDL is a critical decontamination product used by the U.S. military for chemical and biological agent exposure mitigation. CCC's contract history demonstrates sustained strategic importance to defense logistics, with the corporation executing hundreds of delivery orders across multiple commodity categories including aircraft components, ammunition, mechanical parts, and specialized equipment. The Medical Supply Chain division routinely procures medical equipment and supplies through CCC to support military readiness and personnel protection requirements across the Services.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 10/16/25 |